Bionor Holding AS
919 282 134 ↗Research and experimental development on natural sciences and engineeringAS · est 2017OsloBankruptParent · 1 subsidiarywas BIONOR PHARMA AS →2018
Brreg · companies
headcount series appears after two register changes
Roles from Brreg, shown for business contact only. No birth date is shown or exported (purpose limitation, GDPR Art. 6(1)(f)).
Brreg · company_people
1 registered role
| Styrets leder | Birger Sørensen Multiple boards Serial CEO | 2024-08-27 |
NOK, amounts in thousands
| 2024 | 2025 | ||
|---|---|---|---|
| Revenue | |||
| Operating result | −81 | ||
| Result before tax | −149 | ||
| Net result | −149 | ||
| Total assets | 40 | ||
| Equity | −819 |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Operating result | −81 | ||||||
| Result before tax | −149 | ||||||
| Net result | −149 | ||||||
| Total assets | 40 | ||||||
| Equity | −819 |
Regnskapsregisteret · company_revenue · FY2024 (company)
| 2024 | 2025 | ||
|---|---|---|---|
| IMMUNOR AS | 36 | 36 | — |
| JAKOB HATTELAND HOLDING AS | 7 | 14 | — |
| WIVEL INVEST AS | 12 | 12 | — |
| A A HOLDING AS | 10 | 10 | — |
| JAHATT AS | 7 | — | — |
| SVENSKA HANDELSBANKEN AB | 7 | — | — |
| APEX CAPITAL AS | 3 | 3 | — |
| MALISE AS | 2 | 2 | — |
| SMERUD MEDICAL RESEARCH INTERNATIONAL AS | 3 | 3 | — |
| SOLON EIENDOM AS | 2 | 2 | — |
| + 12 smaller holders |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| IMMUNOR AS | 39 | 38 | 38 | 36 | 36 | 36 | — |
| JAKOB HATTELAND HOLDING AS | 6 | 7 | 7 | 7 | 7 | 14 | — |
| WIVEL INVEST AS | 13 | 13 | 13 | 12 | 12 | 12 | — |
| A A HOLDING AS | 11 | 11 | 11 | 10 | 10 | 10 | — |
| JAHATT AS | 8 | 8 | 8 | 7 | 7 | — | — |
| SVENSKA HANDELSBANKEN AB | 5 | 5 | 5 | 7 | 7 | — | — |
| APEX CAPITAL AS | 4 | 4 | 4 | 3 | 3 | 3 | — |
| MALISE AS | 4 | 4 | 2 | 2 | 2 | 2 | — |
| SMERUD MEDICAL RESEARCH INTERNATIONAL AS | — | — | — | 3 | 3 | 3 | — |
| SOLON EIENDOM AS | 2 | 2 | 2 | 2 | 2 | 2 | — |
| + 12 smaller holders |
Aksjonærregisteret · company_ownership · 2025 · both directions
register ledger · owners
| 2025-12-31 | own− | SVENSKA HANDELSBANKEN AB exited (held 6.8 pct) | |
| 2025-12-31 | own− | JAHATT AS exited (held 7.5 pct) |
No recorded tender wins.
Relevant open tenders — matched · NACE 72.100 ↔ CPVsubscribers sharpen matches with per-company keywords
open-tender matching (NACE ↔ CPV) awaits Intelligo's open-tenders view
Doffin/TED · company_tender_wins · 2026-08-17
No job ads on record in the last 12 months.
NAV Arbeidsplassen · company_job_ad_months
Group revenue —Group net kr -316kTenders won 0Rolled up across the parent + 1 subsidiary — Bionor Immuno AS alone is —.
rollup estimate · filed konsernregnskap not yet in Intelligo
| Bionor Immuno AS | 100% | Research and experimental development on natural sciences and engineering |
Aksjonærregisteret · company_ownership · 2025 · both directions
This company's annual report has not been read yet. The filed figures above come from the accounts form; everything the board wrote around them is in the PDF, which is read on request.
Regnskapsregisteret (årsberetning) · company_annual_reports
registered 2017-07-11audit opt-out 2024-11-19
Brreg · companies
register ledger · 4 events
| 2026-07-25 | reg | bankruptcy: bankrupt | False -> True |
| 2026-07-21 | reg | bankruptcy: konkurs | False -> True |
| 2025-12-31 | own− | SVENSKA HANDELSBANKEN AB exited (held 6.8 pct) | |
| 2025-12-31 | own− | JAHATT AS exited (held 7.5 pct) |
Skiwo · company_events